Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aclaris Therapeutics, Inc. - Common Stock
(NQ:
ACRS
)
1.870
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aclaris Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Insiders Buying Freshpet And 2 Other Stocks
August 29, 2023
Although U.S. stocks closed higher on Monday, there were a few notable insider trades.
Via
Benzinga
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
These two low-priced healthcare stocks could skyrocket within the next 12 months.
Via
The Motley Fool
Why Aclaris Therapeutics Topped the Market on Tuesday
June 13, 2023
Investors were cheered by the latest laboratory news from the company.
Via
The Motley Fool
Aclaris Therapeutics Earnings Perspective: Return On Capital Employed
May 22, 2023
Via
Benzinga
Aclaris Therapeutics's Earnings Outlook
May 05, 2023
Via
Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
April 24, 2023
Biotech stocks with no earnings, no cash, and no path to profit will have no chance at survival. Here's three such biotech stocks to avoid.
Via
InvestorPlace
(ACRS) - Analyzing Aclaris Therapeutics's Short Interest
March 08, 2023
Via
Benzinga
Analyst Ratings for Aclaris Therapeutics
March 07, 2023
Via
Benzinga
Why Aclaris Therapeutics Is Crashing Today
March 06, 2023
The company announced disappointing results from a phase 2a clinical study.
Via
The Motley Fool
Why Aclaris Therapeutics Stock Is Plunging Today
March 06, 2023
Via
Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
Via
Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 07, 2023
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the...
Via
Benzinga
Aclaris Therapeutics's Return On Capital Employed Insights
February 27, 2023
Via
Benzinga
Looking Into Aclaris Therapeutics's Return On Capital Employed
December 05, 2022
Via
Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
March 07, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
March 07, 2023
Wells Fargo cut the price target for Cheniere Energy, Inc. (NYSE: LNG) from $236 to $230. Wells Fargo analyst Michael Blum maintained an Overweight rating. Cheniere Energy shares fell 4.8% to close at...
Via
Benzinga
These 2 Biotech Stocks Made Big Monday Moves
March 06, 2023
Find out which was the winner and which was the loser.
Via
The Motley Fool
Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
March 06, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday. The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P...
Via
Benzinga
As Focus Shifts From Hidradenitis Suppurativa, Analyst Seems Bullish On Aclaris
March 06, 2023
Aclaris Therapeutics Inc (NASDAQ: ACRS) flunked a 12-week, Phase 2a study of zunsemetinib (ATI-450) for moderate to severe hidradenitis suppurativa.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 06, 2023
On Monday, 36 companies set new 52-week lows.
Via
Benzinga
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 06, 2023
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 06, 2023
Via
Benzinga
Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
March 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500...
Via
Benzinga
Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January
March 06, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 33,471.14 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
Via
Benzinga
Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal
December 04, 2022
Full-Life Technologies, a Brussels-Shanghai radiotherapeutics company, will acquire Focus-X Therapeutics for up to $245 million. Using its proprietary peptide engineering technology, Focus-X has built...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
10 Best Stocks to Buy Now in December
December 01, 2022
These beaten-down stocks have significant upside.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
October 06, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.